SEARCH RESULTS FOR:

Mexico
Petrochemicals & Chemicals

Rodrigo Gutierrez

CEO, GTM HOLDINGS
GTM Holdings explains its outlook for the Latin American industrial and specialty chemicals market for the next year.
Petrochemicals & Chemicals
Argentina

Martin Cini

DIRECTOR, COPSA COMBUSTIBLES, QUÍMICOS Y ESPECIALIDADES
Copsa is an Argentinian petrochemical company currently expanding its products and services.
Mining
DRC

Amedeo Anniciello

CEO, STANDARD BANK DRC
Standard Bank DRC builds on its international and African network in an effort to become the preeminent corporate investment bank in DRC.
Pharma & Life Sciences
India

Dr. Sharvil Patel

MANAGING DIRECTOR, ZYDUS CADILA
India Pharmaceuticals 2019
Zydus Cadila ranks fourth in the Indian pharmaceutical industry, with a strong global presence in the U.S., Europe, Latin America and South Africa, alongside 25 other emerging markets worldwide.
Mining
Canada

Randy Smallwood

PRESIDENT & CEO, WHEATON PRECIOUS METALS
WPM predicts that its portfolio of precious metal streams is entering a ‘harvest period’.
Oil & Gas
Mozambique
Angola

Andrew Schnitzer da Silva

CEO, ASCENDING
Africa Oil and Gas 2019
Ascending is an HR service provider focused on workforce management solutions in Angola and Mozambique for the extraction industries.
United States
Pharma & Life Sciences

US Biopharmaceutical Investment Climate

United States Biopharmaceuticals 2020
Robust M&A displays value despite pushback.
Pharma & Life Sciences
Turkey

Turkey Pharmaceuticals: Bringing All Actors Together

Turkey Pharmaceuticals & Biopharmaceuticals 2020
Industry, university, investors - the two-way bridge to the knowledge gap.
United States
Pharma & Life Sciences

Arda Ural

PARTNER AND LIFE SCIENCES SECTOR STRATEGY AND TRANSACTIONS LEADER, ERNST & YOUNG LLP
United States Biopharmaceuticals 2020
EY US Life Science comments on the trends currently influencing the life science industry in the US.
United States
Pharma & Life Sciences

Christopher S. Eklund

MANAGING DIRECTOR, J.W. CHILDS ASSOCIATES LP
United States Biopharmaceuticals 2020
J.W. Childs Associates is a private equity firm with investments in biotech.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL